Disease associated variation - GWASdb Chr Pos SNP ID(dbSNP 142) Ref Alt Ori SNP ID P-value Drug Name Drug Anno GWAS Trait HPO ID DO ID AA Type Trait or Drug 17 78641361 rs7218924 T C rs7218924 0.0003651 INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 T intron GWASdb_drug 17 78641361 rs7218924 T C rs7218924 3.65E-04 LEUCOVORIN|METHOTREXATE SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 T intron GWASdb_drug 17 78683460 rs8068064 G A rs8068064 0.0003148 INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 G intron GWASdb_drug 17 78683460 rs8068064 G A rs8068064 3.15E-04 LEUCOVORIN|METHOTREXATE SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 G intron GWASdb_drug 17 78685176 rs1564868 C T rs1564868 0.0003147 INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 A intron GWASdb_drug 17 78685176 rs1564868 C T rs1564868 3.15E-04 LEUCOVORIN|METHOTREXATE SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 A intron GWASdb_drug 17 78694997 rs7503911 C T rs7503911 0.0003164 INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 C intron GWASdb_drug 17 78694997 rs7503911 C T rs7503911 3.16E-04 LEUCOVORIN|METHOTREXATE SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 C intron GWASdb_drug 17 78712423 rs6565479 A G rs6565479 0.0003255 INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 G intron GWASdb_drug 17 78712423 rs6565479 A G rs6565479 3.26E-04 LEUCOVORIN|METHOTREXATE SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 G intron GWASdb_drug 17 78726261 rs4969230 T C rs4969230 1.72E-04 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 T intron GWASdb_drug 17 78726261 rs4969230 T C rs4969230 0.0006811 INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 T intron GWASdb_drug 17 78726261 rs4969230 T C rs4969230 6.81E-04 LEUCOVORIN|METHOTREXATE SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 T intron GWASdb_drug 17 78726575 rs3898096 G A rs3898096 0.00021 METHIONINE CASPASE 1|CASPASE 9|CASP9 PROTEIN, HUMAN|5'-METHYLTHIOADENOSINE|APIP PROTEIN, HUMAN|DEOXYADENOSINES|THIONUCLEOSIDES|APOPTOSIS REGULATORY PROTEINS Salmonella-induced pyroptosis NA NA G intron GWASdb_drug 17 78732673 rs4969235 A T rs4969235 0.0006856 INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 T intron GWASdb_drug 17 78732673 rs4969235 A T rs4969235 6.86E-04 LEUCOVORIN|METHOTREXATE SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 T intron GWASdb_drug 17 78746363 rs4969404 C T rs4969404 0.0006956 INFLIXIMAB|ADALIMUMAB|IMMUNOGLOBULIN G TUMOR NECROSIS FACTOR-ALPHA|ANTIRHEUMATIC AGENTS|ANTIBODIES, MONOCLONAL, HUMANIZED|TNFR-FC FUSION PROTEIN|ANTIBODIES, MONOCLONAL|RECEPTORS, TUMOR NECROSIS FACTOR Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 C intron GWASdb_drug 17 78746363 rs4969404 C T rs4969404 6.96E-04 LEUCOVORIN|METHOTREXATE SLCO1B1 PROTEIN, HUMAN|ORGANIC ANION TRANSPORTERS Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 C intron GWASdb_drug 17 78779981 rs4969277 C T rs4969277 1.59E-05 TAMSULOSIN ADRENERGIC ALPHA-1 RECEPTOR ANTAGONISTS|SULFONAMIDES Serum tamsulosin hydrochloride concentration HPOID:0012220 DOID:11132 C intron GWASdb_drug 17 78816908 rs7219745 C A rs7219745 5.61E-04 GEMCITABINE|CYTARABINE MANNOSYLTRANSFERASES|PIGB PROTEIN, HUMAN|RNA, SMALL INTERFERING|DEOXYCYTIDINE Response to cytidine analogues (gemcitabine) HPOID:0002664 DOID:162 A intron GWASdb_drug 17 78895153 rs9901846 A G rs9901846 9.51E-04 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 G intron GWASdb_drug 17 78895889 rs9908270 C A rs9908270 7.11E-04 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 A intron GWASdb_drug 17 78912354 rs7219318 T C rs7219318 8.80E-04 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_drug 17 78916953 rs1468033 G A rs1468033 1.15E-06 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 G intron GWASdb_drug 17 78916953 rs1468033 G A rs1468033 6.22E-05 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 G intron GWASdb_drug 17 78925950 rs6420481 T C rs6420481 2.26E-04 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_drug 17 78925950 rs6420481 T C rs6420481 7.24E-06 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_drug 17 78928792 rs7225525 C T rs7225525 3.52E-06 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_drug 17 78928792 rs7225525 C T rs7225525 8.38E-05 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_drug 17 78929020 rs7224748 G A rs7224748 3.52E-06 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 G intron GWASdb_drug 17 78929020 rs7224748 G A rs7224748 8.38E-05 ALDOSTERONE BIOLOGICAL MARKERS|NATRIURETIC PEPTIDE, BRAIN|RENIN Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 G intron GWASdb_drug 17 78524130 rs5003528 C T rs5003528 6.74E-04 Insulin resistance HPOID:0000855 DOID:9352 T intron GWASdb_trait 17 78524244 rs4627412 G A rs4627412 0.0000463 Otitis media (children 3 years old or younger) HPOID:0000388 DOID:10754 G intron GWASdb_trait 17 78524407 rs9911978 G A rs9911978 0.0000463 Otitis media (children 3 years old or younger) HPOID:0000388 DOID:10754 A intron GWASdb_trait 17 78549734 rs4396581 T C rs4396581 5.84E-05 Multiple complex diseases HPOID:0000118 NA T intron GWASdb_trait 17 78556325 rs4075782 C T rs4075782 4.72E-05 Lymphocyte counts HPOID:0004332|HPOID:0002665 DOID:2841|DOID:1240|DOID:0060058|DOID:614|DOID:1287 C intron GWASdb_trait 17 78573872 rs9913181 T G rs9913181 5.29E-04 Prostate cancer mortality HPOID:0012125 DOID:10283 T intron GWASdb_trait 17 78591111 rs7503807 A C rs7503807 2.00E-08 Obesity HPOID:0001513 DOID:9970 A intron GWASdb_trait 17 78594754 rs8075393 C T rs8075393 2.90E-05 Urinary metabolites HPOID:0000079 DOID:557 C intron GWASdb_trait 17 78596040 rs901064 A G rs901064 1.16E-04 Multiple complex diseases HPOID:0000118 NA A intron GWASdb_trait 17 78596158 rs12952285 C G rs12952285 7.97E-04 Prostate cancer mortality HPOID:0012125 DOID:10283 C intron GWASdb_trait 17 78634810 rs12939076 C A rs12939076 0.0002 Migraine HPOID:0002076 DOID:6364 C intron GWASdb_trait 17 78641361 rs7218924 T C rs7218924 0.0003651 Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 T intron GWASdb_trait 17 78641361 rs7218924 T C rs7218924 3.65E-04 Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 T intron GWASdb_trait 17 78683460 rs8068064 G A rs8068064 0.0003148 Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 G intron GWASdb_trait 17 78683460 rs8068064 G A rs8068064 3.15E-04 Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 G intron GWASdb_trait 17 78685176 rs1564868 C T rs1564868 0.0003147 Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 A intron GWASdb_trait 17 78685176 rs1564868 C T rs1564868 3.15E-04 Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 A intron GWASdb_trait 17 78694997 rs7503911 C T rs7503911 0.0003164 Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 C intron GWASdb_trait 17 78694997 rs7503911 C T rs7503911 3.16E-04 Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 C intron GWASdb_trait 17 78706517 rs2315921 A T rs2315921 8.83E-04 Type 2 diabetes HPOID:0005978 DOID:9352 A intron GWASdb_trait 17 78708418 rs9915378 A G rs9915378 0.000853283 Hypertension (early onset hypertension) HPOID:0000822 DOID:10763 G intron GWASdb_trait 17 78712423 rs6565479 A G rs6565479 0.0003255 Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 G intron GWASdb_trait 17 78712423 rs6565479 A G rs6565479 3.26E-04 Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 G intron GWASdb_trait 17 78726261 rs4969230 T C rs4969230 1.72E-04 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 T intron GWASdb_trait 17 78726261 rs4969230 T C rs4969230 0.000590874 Hypertension (early onset hypertension) HPOID:0000822 DOID:10763 T intron GWASdb_trait 17 78726261 rs4969230 T C rs4969230 0.0006811 Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 T intron GWASdb_trait 17 78726261 rs4969230 T C rs4969230 6.81E-04 Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 T intron GWASdb_trait 17 78726575 rs3898096 G A rs3898096 0.00021 Salmonella-induced pyroptosis NA NA G intron GWASdb_trait 17 78732673 rs4969235 A T rs4969235 0.0006856 Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 T intron GWASdb_trait 17 78732673 rs4969235 A T rs4969235 6.86E-04 Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 T intron GWASdb_trait 17 78737287 rs7215564 C T rs7215564 6.06E-05 Cognitive performance HPOID:0100543 DOID:1561 T intron GWASdb_trait 17 78737287 rs7215564 C T rs7215564 2.00E-06 Myopia (pathological) HPOID:0000545 DOID:11830 T intron GWASdb_trait 17 78746363 rs4969404 C T rs4969404 0.0006956 Anti-TNF treatment response in rheumatoid arthritis (by DAS-28 score change at 3 months) HPOID:0001370 DOID:7148 C intron GWASdb_trait 17 78746363 rs4969404 C T rs4969404 6.96E-04 Methotrexate clearance (acute lymphoblastic leukemia) HPOID:0006721 DOID:9952|DOID:12603 C intron GWASdb_trait 17 78779981 rs4969277 C T rs4969277 0.0000159 Panic disorder HPOID:0100851 DOID:594 C intron GWASdb_trait 17 78779981 rs4969277 C T rs4969277 1.59E-05 Serum tamsulosin hydrochloride concentration HPOID:0012220 DOID:11132 C intron GWASdb_trait 17 78784312 rs9915426 A G rs9915426 4.00E-06 Urinary metabolites HPOID:0000079 DOID:557 G intron GWASdb_trait 17 78784925 rs2333990 G A rs2333990 9.31E-04 Oral cancers (chewing tobacco related) HPOID:0012290 DOID:1749|DOID:403 C intron GWASdb_trait 17 78798154 rs6565481 C T rs6565481 3.68E-04 Multiple complex diseases HPOID:0000118 NA C intron GWASdb_trait 17 78803575 rs7216306 A G rs7216306 6.80E-06 Urinary metabolites HPOID:0000079 DOID:557 A intron GWASdb_trait 17 78816908 rs7219745 C A rs7219745 5.61E-04 Response to cytidine analogues (gemcitabine) HPOID:0002664 DOID:162 A intron GWASdb_trait 17 78822217 rs2589155 G A rs2589155 4.98E-04 Multiple complex diseases HPOID:0000118 NA T intron GWASdb_trait 17 78827863 rs2672893 A G rs2672893 1.57E-04 Parkinson's disease HPOID:0001300 DOID:14330 C intron GWASdb_trait 17 78827863 rs2672893 A G rs2672893 2.63E-04 Alzheimer's disease (late onset) HPOID:0002511 DOID:10652 C intron GWASdb_trait 17 78835678 rs908241 G A rs908241 7.83E-04 Nicotine smoking HPOID:0000707 DOID:0050742 C intron GWASdb_trait 17 78872953 rs12232521 A G rs12232521 3.76E-04 Prostate cancer mortality HPOID:0012125 DOID:10283 G intron GWASdb_trait 17 78877735 rs868432 G A rs868432 3.93E-04 Nicotine smoking HPOID:0000707 DOID:0050742 C intron GWASdb_trait 17 78885858 rs7220348 C A rs7220348 5.95E-05 Cervical cancer HPOID:0003319 DOID:4362 C intron GWASdb_trait 17 78895889 rs9908270 C A rs9908270 7.11E-04 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 A intron GWASdb_trait 17 78895889 rs9908270 C A rs9908270 9.41E-05 Blood Pressure HPOID:0011025 DOID:10763 A intron GWASdb_trait 17 78895889 rs9908270 C A rs9908270 8.94E-05 Blood Pressure HPOID:0011025 DOID:10763 A intron GWASdb_trait 17 78910629 rs11653325 T C rs11653325 4.57E-04 Nicotine smoking HPOID:0000707 DOID:0050742 C intron GWASdb_trait 17 78912354 rs7219318 T C rs7219318 8.80E-04 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_trait 17 78912354 rs7219318 T C rs7219318 7.90E-05 Blood Pressure HPOID:0011025 DOID:10763 C intron GWASdb_trait 17 78914748 rs6420480 G A rs6420480 6.19E-04 Depression (quantitative trait) HPOID:0000716 DOID:1596 A intron GWASdb_trait 17 78916953 rs1468033 G A rs1468033 1.15E-06 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 G intron GWASdb_trait 17 78916953 rs1468033 G A rs1468033 6.22E-05 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 G intron GWASdb_trait 17 78916953 rs1468033 G A rs1468033 3.05E-05 Blood Pressure HPOID:0011025 DOID:10763 G intron GWASdb_trait 17 78916953 rs1468033 G A rs1468033 1.28E-05 Blood Pressure HPOID:0011025 DOID:10763 G intron GWASdb_trait 17 78916953 rs1468033 G A rs1468033 7.00E-05 Blood Pressure HPOID:0011025 DOID:10763 G intron GWASdb_trait 17 78919920 rs2271612 C T rs2271612 6.50E-05 Diabetic retinopathy HPOID:0000819|HPOID:0000488 DOID:8947 T intron GWASdb_trait 17 78925649 rs8074171 G A rs8074171 0.0000083 Mean arterial pressure HPOID:0001677 DOID:3393 G intron GWASdb_trait 17 78925950 rs6420481 T C rs6420481 2.26E-04 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_trait 17 78925950 rs6420481 T C rs6420481 7.24E-06 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_trait 17 78928792 rs7225525 C T rs7225525 3.52E-06 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_trait 17 78928792 rs7225525 C T rs7225525 8.38E-05 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 C intron GWASdb_trait 17 78929020 rs7224748 G A rs7224748 3.52E-06 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 G intron GWASdb_trait 17 78929020 rs7224748 G A rs7224748 8.38E-05 Blood pressure, CVD RF and other traits (body mass index (BMI), waist:hip ratio, renin activity in plasma, aldosterone concentration in plasma, BNP levels in plasma, alcohol consumption) HPOID:0011025 DOID:10763 G intron GWASdb_trait

Disease associated variation - OMIM Ensembl_gene_ID Approved Gene Symbol MIM Number ENSG00000141564.13 RPTOR 607130